Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $1.62 Million - $1.87 Million
6,107 New
6,107 $1.16 Million
Q1 2019

May 16, 2019

SELL
$216.71 - $338.96 $328,965 - $514,541
-1,518 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $371,797 - $470,921
-1,335 Reduced 46.79%
1,518 $457,000
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $71,322 - $93,270
243 Added 9.31%
2,853 $1.01 Million
Q2 2018

Aug 10, 2018

SELL
$257.52 - $306.91 $1.33 Million - $1.59 Million
-5,169 Reduced 66.45%
2,610 $757,000
Q1 2018

May 22, 2018

SELL
$260.13 - $367.91 $386 Million - $546 Million
-1,483,309 Reduced 99.48%
7,779 $1.49 Million
Q1 2018

May 21, 2018

BUY
$260.13 - $367.91 $386 Million - $546 Million
1,485,089 Added 24755.61%
1,491,088 $1.49 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $1.85 Million - $2.07 Million
5,999
5,999 $2.04 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.